404 related articles for article (PubMed ID: 21057539)
41. Development of microRNA-145 for therapeutic application in breast cancer.
Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
[TBL] [Abstract][Full Text] [Related]
42. Detection of microRNAs in prostate cancer cells by microRNA array.
Tang X; Tang X; Gal J; Kyprianou N; Zhu H; Tang G
Methods Mol Biol; 2011; 732():69-88. PubMed ID: 21431706
[TBL] [Abstract][Full Text] [Related]
43. MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes.
Bockmeyer CL; Christgen M; Müller M; Fischer S; Ahrens P; Länger F; Kreipe H; Lehmann U
Breast Cancer Res Treat; 2011 Dec; 130(3):735-45. PubMed ID: 21409395
[TBL] [Abstract][Full Text] [Related]
44. The effect of miR-7 on behavior and global protein expression in glioma cell lines.
Lu ZJ; Liu SY; Yao YQ; Zhou YJ; Zhang S; Dai L; Tian HW; Zhou Y; Deng HX; Yang JL; Luo F
Electrophoresis; 2011 Dec; 32(24):3612-20. PubMed ID: 22120825
[TBL] [Abstract][Full Text] [Related]
45. MiRNA expression analysis of cancer-associated fibroblasts and normal fibroblasts in breast cancer.
Zhao L; Sun Y; Hou Y; Peng Q; Wang L; Luo H; Tang X; Zeng Z; Liu M
Int J Biochem Cell Biol; 2012 Nov; 44(11):2051-9. PubMed ID: 22964023
[TBL] [Abstract][Full Text] [Related]
46. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
Majumder M; Landman E; Liu L; Hess D; Lala PK
Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
[TBL] [Abstract][Full Text] [Related]
47. Inferring coregulation of transcription factors and microRNAs in breast cancer.
Wu JH; Sun YJ; Hsieh PH; Shieh GS
Gene; 2013 Apr; 518(1):139-44. PubMed ID: 23246694
[TBL] [Abstract][Full Text] [Related]
48. Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells.
Burnett RM; Craven KE; Krishnamurthy P; Goswami CP; Badve S; Crooks P; Mathews WP; Bhat-Nakshatri P; Nakshatri H
Oncotarget; 2015 May; 6(14):12682-96. PubMed ID: 25926557
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA and gene expression analysis of melatonin-exposed human breast cancer cell lines indicating involvement of the anticancer effect.
Lee SE; Kim SJ; Youn JP; Hwang SY; Park CS; Park YS
J Pineal Res; 2011 Oct; 51(3):345-52. PubMed ID: 21615491
[TBL] [Abstract][Full Text] [Related]
50. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.
Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S
Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665
[TBL] [Abstract][Full Text] [Related]
51. Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.
Taipaleenmäki H; Browne G; Akech J; Zustin J; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
Cancer Res; 2015 Apr; 75(7):1433-44. PubMed ID: 25634212
[TBL] [Abstract][Full Text] [Related]
52. MicroRNA-18a inhibits hypoxia-inducible factor 1α activity and lung metastasis in basal breast cancers.
Krutilina R; Sun W; Sethuraman A; Brown M; Seagroves TN; Pfeffer LM; Ignatova T; Fan M
Breast Cancer Res; 2014 Jul; 16(4):R78. PubMed ID: 25069832
[TBL] [Abstract][Full Text] [Related]
53. MicroRNA expression profile of MCF-7 human breast cancer cells and the effect of green tea polyphenon-60.
Fix LN; Shah M; Efferth T; Farwell MA; Zhang B
Cancer Genomics Proteomics; 2010; 7(5):261-77. PubMed ID: 20952761
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2.
Shatseva T; Lee DY; Deng Z; Yang BB
J Cell Sci; 2011 Aug; 124(Pt 16):2826-36. PubMed ID: 21807947
[TBL] [Abstract][Full Text] [Related]
55. miR-490-3p inhibits the growth and invasiveness in triple-negative breast cancer by repressing the expression of TNKS2.
Jia Z; Liu Y; Gao Q; Han Y; Zhang G; Xu S; Cheng K; Zou W
Gene; 2016 Nov; 593(1):41-47. PubMed ID: 27506313
[TBL] [Abstract][Full Text] [Related]
56. miR-200-containing extracellular vesicles promote breast cancer cell metastasis.
Le MT; Hamar P; Guo C; Basar E; Perdigão-Henriques R; Balaj L; Lieberman J
J Clin Invest; 2014 Dec; 124(12):5109-28. PubMed ID: 25401471
[TBL] [Abstract][Full Text] [Related]
57. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors.
Tahiri A; Leivonen SK; Lüders T; Steinfeld I; Ragle Aure M; Geisler J; Mäkelä R; Nord S; Riis ML; Yakhini Z; Kleivi Sahlberg K; Børresen-Dale AL; Perälä M; Bukholm IR; Kristensen VN
Carcinogenesis; 2014 Jan; 35(1):76-85. PubMed ID: 24104550
[TBL] [Abstract][Full Text] [Related]
58. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11.
Liu XX; Li XJ; Zhang B; Liang YJ; Zhou CX; Cao DX; He M; Chen GQ; He JR; Zhao Q
FEBS Lett; 2011 May; 585(9):1363-7. PubMed ID: 21510944
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA profiling of the pubertal mouse mammary gland identifies miR-184 as a candidate breast tumour suppressor gene.
Phua YW; Nguyen A; Roden DL; Elsworth B; Deng N; Nikolic I; Yang J; Mcfarland A; Russell R; Kaplan W; Cowley MJ; Nair R; Zotenko E; O'Toole S; Tan SX; James DE; Clark SJ; Kouros-Mehr H; Swarbrick A
Breast Cancer Res; 2015 Jun; 17(1):83. PubMed ID: 26070602
[TBL] [Abstract][Full Text] [Related]
60. [Screening and identification of potential miRNA involved in ovarian cancer invasion and metastasis].
Liang SH; Li J; Al-beit M; Zhang J; Ma D; Lu X
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):650-4. PubMed ID: 21122376
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
